| On December 22, 2020, the Corporation announced that it had entered into: (i) a definitive arrangement agreement dated December 21, 2020 (the “Arrangement Agreement”), pursuant to which the Corporation agreed to acquire all of the issued and outstanding common shares (the “Liberty Shares”) of Liberty Health Sciences Inc. (“Liberty”) in exchange for, subject to a collar, share consideration equal to 0.03683 of a share of the Corporation pursuant to the terms of the Arrangement Agreement, for each Liberty Share (the “Liberty Share Consideration”), for a total transaction value of approximately USD $290 million (the “Arrangement”), subject to the satisfaction or waiver (as applicable) of the conditions contained in the Arrangement Agreement, to be completed by way of a statutory plan of arrangement under the Business Corporations Act (British Columbia); and (ii) a letter of intent dated December 21, 2020 (the “Letter of Intent”), pursuant to which the Corporation agreed to work together with GSD NJ LLC (“GSD”) and its equity owners (the “GSD Investors”) in good faith to negotiate and enter into a membership purchase agreement (the “Purchase Agreement”) whereby an affiliate of the Corporation (“Buyer”) will acquire all of the issued and outstanding membership interests of GSD (the “GSD Interests”) in exchange for cash consideration of USD $41,000,000 (the “GSD Cash Consideration”), a promissory note in the amount of USD $30,000,000 (the “GSD Seller Note”), and share consideration of USD $30,000,000 in the form of non-voting common exchangeable shares in Buyer (the “GSD Exchangeable Shares”, and together with the GSD Cash Consideration and the GSD Seller Note, the “Closing Date Consideration”), for a total closing date transaction value of approximately USD $101,000,000 (the “Transaction”), subject to the satisfaction or waiver (as applicable) of the conditions to be contained in the Purchase Agreement. The Letter of Intent contemplates a bridge loan from the Corporation, or its affiliate, to GSD in the amount of USD $15,000,000, bearing interest of 9% per annum on the amount outstanding thereunder, which shall be used for capital expenditures upon closing of the Transaction (the “Bridge Loan”). Ayr has also agreed to pay GSD Investors a deposit of USD $1,250,000 (the “Deposit”) within two days of signing the Letter of Intent, which shall be refundable under certain circumstances. The Letter of Intent represents a binding obligation of the parties to work together in good faith to negotiate and enter into the Purchase Agreement and the other definitive agreements contemplated therein. In addition, certain terms contained therein, including exclusivity, the Bridge Loan and Deposit provisions, are legally binding on the parties in accordance with their terms. |